| Literature DB >> 24056154 |
Hee Joon Yu1, Jeehun Lee1, Dae Won Seo2, Munhyang Lee3.
Abstract
Hashimoto encephalopathy is a steroid-responsive encephalopathy associated with elevated titers of antithyroid antibodies. Clinical symptoms are characterized by behavioral and cognitive changes, speech disturbance, seizures, myoclonus, psychosis, hallucination, involuntary movements, cerebellar signs, and coma. The standard treatment is the use of corticosteroids along with the treatment of any concurrent dysthyroidism. Other options are immunoglobulins and plasmapheresis. We described symptoms and outcomes on 3 teenage girls with Hashimoto encephalopathy. Presenting symptoms were seizure or altered mental status. One patient took levothyroxine due to hypothyroidism before presentation of Hashimoto encephalopathy. After confirmation of elevated antithyroid antibodies, all patients were treated with steroids. One patient needed plasmapheresis because of the lack of response to steroids and immunoglobulins. Hashimoto encephalopathy should be considered in any patient presenting with acute or subacute unexplained encephalopathy and seizures. Even though the use of steroids is the first line of treatment, plasmapheresis can rescue steroid-resistant patients.Entities:
Keywords: Hashimoto encephalopathy; plasmapheresis; steroid; steroid-resistant Hashimoto encephalopathy
Mesh:
Substances:
Year: 2013 PMID: 24056154 DOI: 10.1177/0883073813499823
Source DB: PubMed Journal: J Child Neurol ISSN: 0883-0738 Impact factor: 1.987